GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Lukang Pharmaceutical Co Ltd (SHSE:600789) » Definitions » PEG Ratio

Shandong Lukang Pharmaceutical Co (SHSE:600789) PEG Ratio : 2.26 (As of Dec. 12, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Lukang Pharmaceutical Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Shandong Lukang Pharmaceutical Co's PE Ratio without NRI is 26.43. Shandong Lukang Pharmaceutical Co's 5-Year EBITDA growth rate is 11.70%. Therefore, Shandong Lukang Pharmaceutical Co's PEG Ratio for today is 2.26.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Shandong Lukang Pharmaceutical Co's PEG Ratio or its related term are showing as below:

SHSE:600789' s PEG Ratio Range Over the Past 10 Years
Min: 0.96   Med: 2.54   Max: 22.56
Current: 2.26


During the past 13 years, Shandong Lukang Pharmaceutical Co's highest PEG Ratio was 22.56. The lowest was 0.96. And the median was 2.54.


SHSE:600789's PEG Ratio is ranked worse than
60% of 365 companies
in the Drug Manufacturers industry
Industry Median: 1.95 vs SHSE:600789: 2.26

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Shandong Lukang Pharmaceutical Co PEG Ratio Historical Data

The historical data trend for Shandong Lukang Pharmaceutical Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Lukang Pharmaceutical Co PEG Ratio Chart

Shandong Lukang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 30.75 22.27 - 12.10

Shandong Lukang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 12.10 3.04 1.94 1.74

Competitive Comparison of Shandong Lukang Pharmaceutical Co's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Lukang Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Lukang Pharmaceutical Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Lukang Pharmaceutical Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Lukang Pharmaceutical Co's PEG Ratio falls into.



Shandong Lukang Pharmaceutical Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Shandong Lukang Pharmaceutical Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=26.434782608696/11.70
=2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Shandong Lukang Pharmaceutical Co  (SHSE:600789) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Shandong Lukang Pharmaceutical Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Shandong Lukang Pharmaceutical Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Lukang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 152 Taibai West Road, Jining, Shandong, CHN, 272021
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.
Executives
Zhao Wei Director
Peng Xin Director
Dong Kun Director
He De Feng senior management
Gao Xiang You Director
Cheng Jun Director

Shandong Lukang Pharmaceutical Co Headlines

No Headlines